论文部分内容阅读
慢性乙型肝炎临床治愈已成为国内外公认的慢性乙型肝炎患者抗病毒治疗的理想目标，对临床治愈持久性和远期预后的关注也越来越多。本文针对慢性乙型肝炎患者临床治愈优势患者的选择、治疗策略选择及远期预后进行综述。“,”With the further development of clinical cure of chronic hepatitis B, it has gradually become an ideal target of antiviral therapy for patients with chronic hepatitis B at home and abroad. And there are more and more studies on clinical cure persistence and long-term prognosis. In this article, the choice of advantage patients with chronic hepatitis B, treatment strategy and long-term prognosis are reviewed.